Reproducibility of measurements of regional resting and hyperemic myocardial blood flow assessed with PET

Journal of Nuclear Medicine

Volumn 37, Issue 10, 1996, Pages 1626-1631

  Nagamachi, Shigeki ^b   Czernin, Johannes ^a   Kim, Anatole S ^b   Sun, Karl T ^b   Böttcher, Morten ^b   Phelps, Michael E ^b   Schelbert, Heinrich R ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

myocardial blood flow; PET; pharmacologic stress

Indexed keywords

AMMONIA; NITROGEN 13;

ADULT; ARTICLE; FEMALE; HEART MUSCLE BLOOD FLOW; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; HYPEREMIA; MALE; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REPRODUCIBILITY; REST;

ADENOSINE; ADULT; AMMONIA; CORONARY CIRCULATION; DIPYRIDAMOLE; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYPEREMIA; MALE; NITROGEN RADIOISOTOPES; REPRODUCIBILITY OF RESULTS; REST; TOMOGRAPHY, EMISSION-COMPUTED; VASODILATOR AGENTS;

EID: 0029815952     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. 15O. Circulation 1984;70:724-733.
2. 13N ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 1990;15:1032-1042.
3. 15O and dynamic positron emission tomography. Strategy for quantification in relation to the partial-volume effect. Circulation 1988;78:104-115.
4. Krivokapich J, Smith GT, Huang SC, et al. Nitrogen-13-ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation 1989;80:1328-1337.
5. Kuhle W, Porenta G, Huang SC, Phelps M, Schelbert H. Issues in the quantitation of re-oriented cardiac PET images. J Nucl Med 1992;33:1235-1242.
6. 13N-ammonia and re-oriented dynamic positron emission tomographic imaging. Circulation 1992;86:1004-1017.
7. Schelbert HR, Phelps ME, Huang SC, et al. Nitrogen-13- ammonia as an indicator of myocardial blood flow. Circulation 1981;63:1259-1272.
8. Czernin J, Müller P, Chan S, et al. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation 1993;88:62-69.
9. Chan S, Brunken R, Czernin J, et al. Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. J Am Coll Cardiol 1992;20:979-985.
10. Czernin J, Porenta G, Brunken R, et al. Regional blood flow, oxidative metabolism and glucose utilization in patients with recent myocardial infarction. Circulation 1993;88: 884-895.
11. Sambuceti G, Parodi O, Marcassa C, et al. Alteration in regulation of myocardial blood flow in one-vessel coronary artery disease determined by positron emission tomography. Am J Cardiol 1993;72:538-543.
12. Camici P, Chiriatti G, Oorenzoni R, et al. Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13-ammonia and positron emission tomography. J Am Coll Cardiol 1991;17:879-886.
13. Nienaber C, Gambhir S, Vaghaiwalla Mody F, et al. Regional myocardial blood flow and glucose utilization in symptomatic patients with hypertrophic cardiomyopathy. Circulation 1993;87:1580-1590.
14. Bottcher M, Czernin J, Phelps M, Schelbert H. Beneficial effect of β-blockade on myocardial blood flow and vasodilator capacity in humans [Abstract]. J Am Coll Cardiol 1995;22:427A.
15. Czernin J, Barnard RJ, Sun KT, et al. Beneficial effect of cardiovascular conditioning on myocardial blood flow and coronary vasodilator capacity. Circulation 1995;92: 197-204.
16. Uren NG, Crake T, Lefroy DC, DeSilva R, Davies GJ, Maseri A. Delayed recovery of coronary resistive vessel function after coronary angioplasty. J Am Coll Cardiol 1993;21:612-621.
17. 15O. J Am Coll Cardiol 1990;15:119-127.
18. Chan SY, Kobashigawa J, Stevenson LW, Brownfield E, Brunken RC, Schelbert HR. Myocardial blood flow at rest and during pharamacological vasodilation in cardiac transplants during and after successful treatment of rejection. Circulation 1994;90: 204-212.
19. Sawada S, Muzik O, Beanlands R, Wolfe E, Hutchins G, Schwaiger M. Interobserver and interstudy variability of myocardial blood flow and flow-reserve measurements with nitrogen-13-ammonia labeled positron emission tomography. J Nucl Cardiol 1995;2:413-422.
20. Diamond G, Forrester J. Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. N Engl J Med 1979;300:1350-1358.
21. Smits P, Thien TH, van't Laar A. Circulatory effects of coffee in relation to the pharmacokinetics of caffeine. Am J Cardiol 1985;56:958-963.
22. Brown BG, Josephson MA, Peterson RB, et al. Intravenous dipyridamole combined with isometric handgrip for near maximal acute increase in coronary flow in patients with coronary artery disease. Am J Cardiol 1981;48:1077-1085.
23. Olsson RA, Pearson JD. Cardiovascular purinoceptors. Physiol Rev 1990;70:761-84.
24. Wilson R, Laughlin D, Ackell P, et al. Transluminal subselective measurement of coronary blood flow velocity and vasodilator reserve in man. Circulation 1985;72:82-92.
25. Spinks TJ, Guzzardi R, Bellina CR. Performance characteristics of a whole-body positron tomograph. J Nucl Med 1988;29:1833-1841.
26. Weinberg IN, Huang SC, Hoffman EJ, et al. Validation of PET-acquired functions for cardiac studies. J Nucl Med 1988;29:241-247.
27. Gambhir SS, Schwaiger M, Huang SC, et al. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18-deoxyglucose. J Nucl Med 1989;30:359-366.
28. Porenta G, Kuhle W, Czernin J, et al. Semiquantitative assessment of myocardial viability and perfusion utilizing polar map displays of cardiac PET images. J Nucl Med 1992;33:1623-1631.
29. Demer LL, Gould KL, Goldstein RA, et al. Assessment of coronary artery disease seventy by positron emission tomography. Comparison with quantitative arteriography in 193 patients. Circulation 1989;79:825-835.
30. 13N ammonia and positron computed tomography. Am J Cardiol 1982;49:1197-1207.
31. Tamaki N, Yonekura Y, Senda M. et al. Value and limitation of stress thallium-201 single-photon emission computed tomography: comparison with nitrogen-13-ammonia positron tomography. J Nucl Med 1988;29:1181-1188.
32. Marcus M. Autoregulation in the coronary circulation. In: Marcus M, ed. The coronary circulation in health and disease. New York: McGraw-Hill;1983:93-112.
33. Henze E, Huang SC, Ratib O, Hoffman E, Phelps ME, Schelbert HR. Measurement of regional tissue and blood-pool radiotracer concentrations from serial tomographic images of the heart. J Nucl Med 1983;24:987-996.
34. Müller P, Czernin J, Choi Y, et al. Effect of exercise supplementation during adenosine infusion on hyperemic blood flow and flow reserve. Am Heart J 1994;128:52-60.
35. Klocke F, Mates R, Canty JJ, Ellis A. Coronary pressure-flow relationship. Controversial issues and probable implications. Circ Res 1985;56:310-323.
36. Rossen J, Quillen J, Lopez A, Stenberg R, Talman C, Winniford M. Comparison of coronary vasodilation with intravenous dipyridamole and adenosine. J Am Coll Cardiol 1991;18:485-491.
37. Bache R, Cobb F. Effect of maximal coronary vasodilation on transmural myocardial perfusion during tachycardia in the awake dog. Circ Res 1977;41:648-653.
38. Hoffman E. Maximal coronary flow and the concept of coronary vascular reserve. Circulation 1984;70:153-165.
39. Ohtsuka S, Kakihana M, Sugishita Y, Ito I. Effects of the rise in aortic blood pressure on coronary flow reserve in dogs. Jpn Heart J 1987;28:403-412.
40. McGinn A, White C, Wilson R. Interstudy variability of coronary flow reserve: Influence of heart rate, arterial pressure and ventricular preload. Circulation 1990;81: 1319-1330.
41. Klocke F, Ellis A, Canty J, Jr. Interpretation of changes in coronary flow that accompany pharmacologic interventions. Circulation 1987;75(suppl V):34-38.